Search for: "Bristol Myers Squibb Manufacturing Company"
Results 101 - 120
of 161
Sort by Relevance
|
Sort by Date
31 Jan 2013, 2:39 pm
Earlier in February, 2006 Emcure entered into a similar deal with Bristol Myers Squibbs (BMS) for the manufacture of atanzanavir. [read post]
24 Jan 2013, 11:49 am
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
11 Jan 2013, 6:27 pm
The patents for the remaining two drugs – Ixabepilone and Dastinib are owned by Bristol Myers Squibbs (BMS). [read post]
8 Jan 2013, 9:39 am
Bristol-Myers Squibb Co., 2013 U.S. [read post]
10 Sep 2012, 7:28 pm
Mich. 1996); Bristol-Myers Squibb Co. v. [read post]
4 Sep 2012, 1:45 pm
Experts further expected that the new drug will generate more sales to its manufacturer since its competing experimental drug from Bristol-Myers Squibb. [read post]
22 Aug 2012, 7:51 am
Bristol-Myers Squibb Co., resulting in $515 million settlement arising from unlawful conduct including off-label promotion to induce government purchases of the antipsychotic drug Abilify; and United States ex rel. [read post]
22 Aug 2012, 6:09 am
Drug companies including Pfizer, Merck & Co. and Bristol Myers-Squibb Co. are squeezed by rising research costs, the weak global economy and pressure from Europe, China and elsewhere to reduce drug prices. [read post]
24 May 2012, 4:23 am
Bristol-Myers Squibb Co., 2011 WL 2784101, at *3 (D.N.J. 2011), the Court did not hold that the warning label was enough to give notice. [read post]
20 May 2012, 1:11 pm
The number 50 million: The number of people in the US since 1997, that have taken Bristol-Myers Squibb's blood-thinning drug Plavix. [read post]
8 Mar 2012, 3:34 am
Those competitors included AstraZeneca, Merck & Co., Bristol-Myers Squibb Co., GlaxoSmithKline PLC and others that have disclosed investigations for possible FCPA breaches. [read post]
29 Feb 2012, 7:24 am
Squibbs and Sons (now known as Bristol-Myers Squibb) and many other companies including 70 other similar types of synthetic hormones . [read post]
10 Feb 2012, 12:39 pm
., Canada's largest pharmaceutical manufacturer, has paid Bristol-Myers Squibb Co. and Sanofi SA nearly $445 million in damages to end a decade-long patent infringement lawsuit over Apotex' improper sales of its generic version of Plavix. [read post]
28 Oct 2011, 7:00 am
Fla. 2009) (“[w]here a physician fails to review the warnings issued by the manufacturer, proximate cause cannot be established”). [read post]
28 Jul 2011, 3:33 pm
(6) Is it of significance in answering Question 1 that the repackaging company is indicated as the manufacturer in the package leaflet? [read post]
16 Jul 2011, 6:19 am
In April, Bristol-Myers Squibb and Sanofi called for a mass tort designation for the Plavix litigation pending in New Jersey state courts, where at least 40 claims have been filed. [read post]
2 Jun 2011, 12:46 pm
Minnesota Mining & Manufacturing Co., 226 Cal. [read post]
24 Mar 2011, 1:12 pm
Bristol-Myers Squibb, Inc., the employees claim that BMS paid kickbacks to physicians and pharmacists to increase prescriptions and dispensing of the company’s drugs. [read post]
18 Feb 2011, 11:47 am
., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
20 Jan 2011, 12:50 pm
Bristol-Myers Squibb Co., 353 F.3d 848, 852 (10th Cir. 2003); In re Norplant Contraceptive Products Liability Litigation, 955 F. [read post]
